|
|
||||||||
and AP-1 and iNOS signaling
Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia 23298-0281
Submitted 6 May 2004 ; accepted in final form 23 July 2004
Acute systemic hypoxia induces delayed cardioprotection against ischemia (I)-reperfusion (R) injury via inducible nitric oxide synthase (iNOS)-dependent mechanism. Because CoCl2 is known to elicit hypoxia-like responses, we hypothesized that this chemical would mimic the delayed preconditioning effect in the heart. Adult male mice were pretreated with CoCl2 or saline. The hearts were isolated 24 h later and subjected to 20 min of global I and 30 min of R in Langendorff mode. Myocardial infarct size (% of risk area; mean ± SE, n = 68/group) was reduced in mice pretreated with 30 mg/kg CoCl2 (16.1 ± 3.1% vs. 27.6 ± 3.3% with saline control; P < 0.05) without compromising postischemic cardiac function. Higher doses of CoCl2 failed to induce similar protection. Electrophoretic mobility gel shift assay demonstrated significant enhancement in DNA binding activity of hypoxia-inducible factor 1
(HIF-1
) and activator protein 1 (AP-1) in nuclear extracts from CoCl2-treated hearts. Activation of HIF-1
and AP-1 was evident at 30 min and sustained for the next 4 h after CoCl2 injection. In contrast, CoCl2-induced protection was independent of NF-
B activation because no DNA binding or p65 translocation was observed in nuclear extracts. Also, CoCl2-induced cardioprotection was preserved in p50 subunit NF-
B-knockout (KO) mice (11.1 ± 3.0% vs. 25.1 ± 5.0% in saline-treated p50-KO mice; P < 0.05). The infarct-limiting effect of CoCl2 was absent in iNOS-KO mice (20.9 ± 3.0%). We conclude that in vivo administration of CoCl2 preconditions the heart against I/R injury. The delayed protective effect of CoCl2 is achieved through a distinctive signaling mechanism involving HIF-1
, AP-1, and iNOS but independent of NF-
B activation.
ischemia-reperfusion injury; myocardial infarction; hypoxia; nitric oxide synthase; transcription factors
This article has been cited by other articles:
![]() |
E. Belaidi, P. C. Beguin, P. Levy, C. Ribuot, and D. Godin-Ribuot Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H901 - H908. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hill, D. Shukla, M. G.B. Tran, J. Aragones, H. T. Cook, P. Carmeliet, and P. H. Maxwell Inhibition of Hypoxia Inducible Factor Hydroxylases Protects Against Renal Ischemia-Reperfusion Injury J. Am. Soc. Nephrol., January 1, 2008; 19(1): 39 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Prefumo, D. C Gaze, A. T Papageorghiou, P. O Collinson, and B. Thilaganathan First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development Hum. Reprod., July 1, 2007; 22(7): 2029 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gross, G. Buchwalter, H. Dubois-Pot, E. Cler, H. Zheng, and B. Wasylyk The Ternary Complex Factor Net Is Downregulated by Hypoxia and Regulates Hypoxia-Responsive Genes Mol. Cell. Biol., June 1, 2007; 27(11): 4133 - 4141. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Bell, J. E. Clark, D. J. Hearse, and M. J. Shattock Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection Cardiovasc Res, January 1, 2007; 73(1): 153 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Kudej, Y.-T. Shen, A. P. Peppas, C.-H. Huang, W. Chen, L. Yan, D. E. Vatner, and S. F. Vatner Obligatory Role of Cardiac Nerves and {alpha}1-Adrenergic Receptors for the Second Window of Ischemic Preconditioning in Conscious Pigs Circ. Res., November 24, 2006; 99(11): 1270 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Natarajan, F. N. Salloum, B. J. Fisher, R. C. Kukreja, and A. A. Fowler III Hypoxia Inducible Factor-1 Activation by Prolyl 4-Hydroxylase-2 Gene Silencing Attenuates Myocardial Ischemia Reperfusion Injury Circ. Res., January 6, 2006; 98(1): 133 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Lippi, M Franchini, and G C Guidi Cobalt chloride administration in athletes: a new perspective in blood doping? Br. J. Sports Med., November 1, 2005; 39(11): 872 - 873. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |